Antibody Drug Conjugates Market Sees Strong Potential from Oncology Drug Development
Increasing investment in biotechnology infrastructure is supporting the development and production of antibody-drug conjugates. Advanced research facilities and specialized manufacturing capabilities are helping companies strengthen their product pipelines. Market Overview The Antibody Drug Conjugates Market is projected to reach US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...
0 Comentários 0 Compartilhamentos 19 Visualizações 0 Anterior